Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000130407 | SCV000185269 | benign | Hereditary cancer-predisposing syndrome | 2018-10-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000228248 | SCV000288113 | benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000410621 | SCV000487821 | likely benign | Paragangliomas 5 | 2015-11-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001704054 | SCV000730679 | likely benign | not provided | 2021-05-10 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818312 | SCV002069741 | benign | not specified | 2021-04-28 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000130407 | SCV002527717 | benign | Hereditary cancer-predisposing syndrome | 2020-02-26 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001818312 | SCV002773965 | benign | not specified | 2021-07-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000410621 | SCV004045355 | uncertain significance | Paragangliomas 5 | 2023-04-24 | criteria provided, single submitter | clinical testing | This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. |
Prevention |
RCV004532558 | SCV004740150 | benign | SDHA-related disorder | 2019-09-09 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |